Department of Pediatrics, Northwestern University Feinberg School of Medicine, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
Pediatr Res. 2013 Mar;73(3):332-6. doi: 10.1038/pr.2012.185. Epub 2012 Dec 7.
Kawasaki disease (KD) can result in fatal coronary artery (CA) aneurysms, especially if left untreated. Our recent studies of its vascular pathology revealed subacute/chronic vasculitis that begins early in the illness with the proliferation of smooth muscle cell-derived myofibroblasts in a complex extracellular matrix (ECM). We hypothesized that a dysregulation of specific ECM and adhesion molecules occurs in KD CAs.
Gene expression profiling for ECM and adhesion molecules was performed on six acute KD and eight control CAs using a targeted real-time PCR array approach.
Integrins α4 and αM (ITGA4, ITGAM), collagen type I, α1 (COL1A1), and matrix metalloproteinase 7 (MMP7) were significantly upregulated in KD CAs as compared with controls. Immunohistochemistry with anti-ITGAM antibodies revealed expression on inflammatory cells within the CA wall in patients with KD but not in controls.
Integrins ITGA4 and ITGAM are upregulated in KD vasculopathy, probably promoting inflammatory recruitment that stimulates smooth muscle cell transition to myofibroblasts and their proliferation. MMP7 probably enhances myofibroblast proliferation and luminal lesion expansion, and overexpression of COL1A1 may lead to CA stenosis. Identification of the molecular pathogenesis of KD vasculopathy may lead to the development of circulating biomarkers and to directed therapeutic interventions.
川崎病(KD)可导致致命性冠状动脉(CA)瘤,尤其是未经治疗者。我们最近对其血管病理学的研究显示,亚急性/慢性血管炎在疾病早期即出现,平滑肌细胞衍生的肌成纤维细胞在复杂的细胞外基质(ECM)中增殖。我们假设 KD CA 中存在特定 ECM 和黏附分子的失调。
采用靶向实时 PCR 阵列方法,对 6 例急性 KD 和 8 例对照 CA 中的 ECM 和黏附分子进行基因表达谱分析。
与对照组相比,KD CA 中整合素 α4 和 αM(ITGA4、ITGAM)、Ⅰ型胶原α1(COL1A1)和基质金属蛋白酶 7(MMP7)的表达显著上调。用抗 ITGAM 抗体进行免疫组织化学染色显示,KD 患者 CA 壁内的炎症细胞表达,但对照组无表达。
整合素 ITGA4 和 ITGAM 在 KD 血管病变中上调,可能促进炎症细胞募集,刺激平滑肌细胞向肌成纤维细胞转化及其增殖。MMP7 可能增强肌成纤维细胞增殖和管腔病变扩张,COL1A1 的过表达可能导致 CA 狭窄。明确 KD 血管病变的分子发病机制可能会开发出循环生物标志物并进行靶向治疗干预。